DOSAGE,

ROUTE, NURSING
NAME OF MECHANISM DESIRED
AND RESPONSIBILIT
DRUG OF ACTION EFFECT
FREQUEN IES
CY
GENERIC  50  Competiti  This To ensure safety
NAME: mg I.V. vely inhibit drug was of the patient:
q 80 action of given to our
 RANITID histamine patient to  Check the
INE on the h2 prevent intravenous
receptor site irritation of patency
BRAND of the gastric before
NAME: parietal mucosa due administering
cells, to NPO of the drug
 ZANTAC decreasing status
gastric acid  Watch out
CLASSIFICAT secretion for adverse
ION: reaction such
as nausea
 H2 and vomiting,
RECEPTOR body malaise
ANTAGON and pain
IST
 Notify the
Date started: physician if
adverse
February 09 reaction
2010 occurs
 DOSAGE,
ROUTE,
NAME OF MECHANISM DESIRED NURSING
AND
DRUG OF ACTION EFFECT RESPONSIBILITIES
FREQUENC
Y
GENERIC  50 mg  Unknown,  This To potentiate the
NAME: I.V. now a centrally drug is effect of drug:
acting given to
 TRAMA synthetic our  Instruct patient
DOL analgesic patient to take the drug
 50 mg compound to relieve before onset of
BRAND P.O. q 6 not pain intense pain
NAME: chemically
related to  Instruct patient
CLASSIFICA opiod. to take the drug
TION: Through to with a full glass
bind to opiod of water
 OPIOD receptor and
ANALGESI inhibit re Taken with
C uptake of meals
nor-
Date epinephrine To ensure safety of
started: and serotonin the patient

 Februar  Watch out for

y 07 2010 any adverse
reaction like
vomiting,
constipation, and
respiratory
distress

 Warn the
patient not to
stop the drug
abruptly

 Monitor vital
sign especially
the blood
pressure, cardiac
rhythm an d
output
 DOSAGE,
ROUTE,
NAME OF MECHANISM DESIRED NURSING
AND
DRUG OF ACTION EFFECT RESPONSIBILITIES
FREQUE
NCY
GENERIC  500  Direct  This To potentiate the effect
NAME: mg, acting drug is of the drug:
I.V., q trichomon given
 Advise patient to
 Metrodin 8 ocide and to our
complete full course
azole amebecide patient
of therapy even if he
that works to treat feels better
BRAND inside and and  Instruct patient not
NAME: outside the prevent to take alcohol or
intestine. further drugs that contain
It’s infectio alcohol during
CLASSIFICAT thought to n therapy and at least
ION: enter the 48 hours after
cells of therapy is completed
 Anti micro because of disulfiram
protozoal organisms like reaction to
alcohol ingestion
that
 Advice patient to
Date started: contain have a sips of water,
nitroreduct sugarless gum or
 February ase, hard candy to relieve
09, 2010 forming dry mouth
stable
compound To ensure safety of the
s that bind patient:
to bacterial
and  Monitor for and
protozoal report occurrence of
drug induced adverse
DNA to
reactions including
causeloss sore throat, bruising,
of helical bleeding, and joint
structure, pains which may
strand indicate blood
breakage,i dyscrasis (rare)
nhibition of  Monitor for renal
nucleic function: urine output,
acid input and output
synthesis ration,polyuria,pyuria,
BUN and creatinine.
and cell
Decreased output and
death increased
BUN,craetinine may
indicate
nephrotoxicity.
 Monitor for bowel
pattern, discontinue
drug if severe
diarrhea oocurs
 DOSAGE,
ROUTE,
NAME OF MECHANISM DESIRED NURSING
AND
DRUG OF ACTION EFFECT RESPONSIBILITIES
FREQUE
NCY
GENERIC  500  Inhibits  This To potentiate the effect
NAME: mg bacterial drug is of the drugs:
P.O. cell wall given to
 Cefurox O.D. synthesis, our  Instruct patient to
ime rendering patient take the
cell wall to treat medication as
BRAND osmotically and prescribed for the
NAME: unstable, prevent length of time
leading to further ordered even if he
CLASSIFICA cell death infection feels better
TION: by binding
to cell wall To ensure the safety of
 Antibac membrane the client
terial
Second  Assess patient for
generation previous
cephalospori sensitivity
n reaction to
penicillin or other
Date cephalosphorins.
started: Cross sensitivity
between penicillin
 Feebru and cephalosporin
ary 13 is common
2010  Assess renal
function before
and after therapy
urine output
 Monitor for an
adverse reaction
like sore throat,
bruising, bleeding
and joint pain this
may indicate
blood dyscrasis
(rare)
 Advise patient to
report
bloody,mucoid
diarrhea which
may indicate
pseudomembreno
us colitis
 DOSAGE,RO NURSING
NAME OF MECHANISM DESIRED
UTE, AND RESPONSIBILIT
DRUG OF ACTION EFFECT
FREQUENCY IES
GENERIC  1 tab  Unknown  This To potentiate
NAME: P.O. , thought to drug was the effect of the
produce given to drugs:
 Paracet analgesia the Patient
amol by blocking to lower  Increased
pain his body fluid intake
BRAND impulse by temperatur  Instruct
NAME: inhibiting e and perform
synthesis of to the S.O.
CLASSIFICA prostaglandi TSB.
TION: n in the CNS  Instruct
or other S.O. to dress
 Non substances client with
Opioid that light clothing.
Analgesic sensitize  Provide
Antipyretic pain good
receptors to ventilation.
stimulation,
the drug To ensure the
may relieve safety of the
fever client
through
central  Assess
action in the liver
hypothalami function .
c heat –  Monitor
regulating V/S (body
center temperature)
 Advised
patient that
drug is only
for short
term use.
 Warn
Patient that
high doses or
 unsupervised
long term
use can
cause liver
damage

DOSAGE,RO NURSING
NAME OF MECHANISM DESIRED
UTE, AND RESPONSIBILITIE
DRUG OF ACTION EFFECT
FREQUENCY S
 This
GENERIC  1g I.V.  Inhibit To potentiate the
drug was
NAME: q8 cell wall effect of the drugs:
given to
synthesis,
 Ceftriax the
promoting  Instruct
one Patient to
osmotic patient to take
Sodium treat/prev
instability, the medication
ent
usually as prescribed
BRAND infection
bactericid for the length of
NAME:
al time ordered
even if he feels
CLASSIFICA
better
TION:
To ensure the
 Antibac
safety of the client
terial
 Assess
3rd
patient for
generation
previous
cephalospori
sensitivity
n
reaction to
penicillin or
other
cephalosphorins
. Cross
sensitivity
between
penicillin and
cephalosporin is
common
 Assess renal
function before
and after
therapy urine
output
 Advise
patient to report
sore throat,
bruising,
 bleeding and
joint pain (this
may indicate
blood dyscrasia)
 Instruct
patient to watch
out for perineal
itching, fever,
malaise,
redness, pain,
swelling, rash
and diarrhea
(this may
indicate super
infection)

DOSAGE
, ROUTE, NURSING
NAME OF MECHANISM OF DESIRED
AND RESPONSIBILITI
DRUG ACTION EFFECT
FREQUE ES
NCY
GENERIC  1ne  Beta2  This drug To potentiate the
NAME: bule adrenorecepto was given effect of the
q 8° r agonist. At to the drugs:
 Salbuta therapeutic patient to  Place
mol doses it acts relieve patient in
on the beta2 bronchospa comfortable
BRAND adrenorecepto sm sitting or semi
NAME: rs of bronchial fowler’s
muscle, with position
CLASSIFICA little or no  Prescribed
TION: action in fluid (normally
beta1 saline) is filled
 Antiast adrenorecepto in the
hma rs of cardiac coupling
Bronchodilato muscle. compartment
r of nebulizer
chamber
 Encourage
Client to
increase OFI if
tolerated.
 Encourage
Client to
perform
breathing ang
coughing
exercise.

To ensure the
safety of the
client
 Assess for
cardiac
rhythm and
output.
 Maintain a
adrenergic
blocker
(cardioselectiv
e beta –
blocker, such
as atenolol,
should be use
with
respiratory
distress) on
standby in
case cardiac
 arrhythmias
occur.

DOSAGE,RO NURSING
NAME OF MECHANISM DESIRED
UTE, AND RESPONSIBILITI
DRUG OF ACTION EFFECT
FREQUENCY ES
GENERIC  2g q 12  Produces  This To potentiate the
NAME: Incorporated anti- drug was effect of the
to D5W ½ L inflammator given to drugs:
y, analgesic, the
 Sodium
and Patient  Instruct
diclofenac
antipyretic to relief patient to take
effect, pain. vitamin b
BRAND
possibly complex to
NAME:
through increase pain
 tolerance
inhibition of
CLASSIFICA prostaglandi
TION: To ensure the
n synthesis.
safety of the
 Anti- client
inflammat
ory  Assess for
NSAID hypersensitivi
ty to
diclofenac,
aspirin or
other NSAIDs
 Teach the
patient signs
and
symptoms of
G.I. bleeding ,
including
blood in
vomit, urine
or stool;
coffee-ground
vomit; black
tarry stool
 Teach patient
the signs and
symptoms of
damage to
the liver,
including
nausea,
fatigue,
itching,
yellowed skin
or eyes, right
upper
quadrant
tenderness
and flu like
symptoms.

NAME OF DOSAGE, MECHANISM OF DESIRED NURSING

DRUG ROUTE, ACTION EFFECT RESPONSIBILI
AND TIES
FREQUEN
 CY
GENERIC  1tab  A co  This To potentiate
NAME: O.D. enzyme that drug was the effect of the
stimulate given to drugs:
 Vitamin metabolic prevent  Avoid I.V.
B complex function and is anemia / administratio
needed for cell potentiate n because
BRAND replication, diclofenac faster
NAME: hematopoiesis action. systemic
, and elimination
CLASSIFICAT nucleoprotein will reduce
ION: and myelin effectiveness
synthesis. of vitamin
 Multivita
mins To ensure the
safety of the
client
 Teach
patient
about the
side effect
 NAME OF DOSAGE,RO MECHANISM DESIRED NURSING
DRUG UTE, AND OF ACTION EFFECT RESPONSIBILIT
FREQUENCY IES
GENERIC 1 cap O.D.
NAME:

MULTI
VITAMIN

BRAND
NAME:
CLASSIFICATI
ON:

DATE
STARTED:
February 16
2010